Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › miR-155 inhibitors for treating cutaneous T cell lymphoma (CTCL)

miR-155 inhibitors for treating cutaneous T cell lymphoma (CTCL)

US Patent 9771585 · Granted Sep 26, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oligonucleotide-based inhibitors comprising locked nucleic acid motif2019
Oligonucleotide compositions and uses thereof2019
Oligonucleotide compositions and uses thereof2019
Oligonucleotide compositions and uses thereof2019
Oligonucleotide compositions and uses thereof2019
Oligonucleotide compositions and uses thereof2019
MiR-92 inhibitors and uses thereof2019
MiR-92 inhibitors and uses thereof2019
MiR-92 inhibitors and uses thereof2019
Inhibitors of MYH7B and uses thereof2018
miR-29 mimics and uses thereof2018
Oligonucleotide compositions and uses thereof2018